NCT06471400 Developing Strategies to Facilitate Consent of Legally Authorized Representatives to Clinical Trials
| NCT ID | NCT06471400 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital Freiburg |
| Condition | Critical Illness |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2024-06-18 |
| Primary Completion | 2026-06-17 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2024-06-18 with a primary completion date of 2026-06-17.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to gather insights into the perceptions of legal representatives regarding the recruitment process for clinical trials in the intensive care setting when the patients cannot decide for themselves. With this information, effective strategies will be developed to increase involvement and the feeling of ownership of LARs of (potential) participants in clinical trials and thus enhance and facilitate patient recruitment for clinical trials. The single-arm study design does not include a choice of comparator, as the focus of this trial is to explore the perceptions of the participants at first hand without comparing different cohorts or strategies.
Eligibility Criteria
Inclusion Criteria: * The study will include LARs of adult patients aged 18 years or older who are admitted to the Freiburg University Medical Center in Germany. Exclusion Criteria: * LARs who have expressed their unwillingness to participate in the study or have objected to the measures implemented in the study will not be included.
Contact & Investigator
Alexander Supady, MD
PRINCIPAL INVESTIGATOR
Freiburg University Medical Center
Frequently Asked Questions
Who can join the NCT06471400 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Critical Illness. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06471400 currently recruiting?
Yes, NCT06471400 is actively recruiting participants. Contact the research team at alexander.supady@uniklinik-freiburg.de for enrollment information.
Where is the NCT06471400 trial being conducted?
This trial is being conducted at Freiburg im Breisgau, Germany.
Who is sponsoring the NCT06471400 clinical trial?
NCT06471400 is sponsored by University Hospital Freiburg. The principal investigator is Alexander Supady, MD at Freiburg University Medical Center. The trial plans to enroll 50 participants.